UCM-05194
UCM-05194 is a selective LPA1 receptor agonist with activity to improve neuropathic pain. UCM-05194 is a LPA1 agonist that exhibits potent and selective properties in its pharmacologically similar properties. UCM-05194 triggers LPA1-mediated cellular effects and leads to internalization of the receptor, resulting in functional inactivation in primary sensory neurons. UCM-05194 effectively reduces pain perception in in vivo models. UCM-05194 can be used to conduct research on progressive systemic diseases[1].
Product Specifications
CAS Number
[2411412-36-5]
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ucm-05194.html
Purity
90.0
Smiles
O=P(O)(O)OC[C@@H](CBr)OC(CCCCCCCCCC1=CC=CC=C1)=O
Molecular Formula
C19H30BrO6P
Molecular Weight
465.32
References & Citations
[1]A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal beta-Defensin 3 Antibody [DyLight 680]](https://cdn.genprice.uk/genprice/genprice4.png)
![Rabbit Polyclonal PRICKLE2 Antibody [CoraFluor 1]](https://cdn.genprice.uk/genprice/genprice2.png)